We aimed to explore the underlying mechanism of Tripterygium glycosides (TGs) in treating systemic lupus erythematosus (SLE) through network-pharmacology approach.
Methods
The protein targets of TGs’ three active ingredients (triptolide, tripterine, and wilforlide) and SLE were identified by database search. Then, the intersection of the two groups was studied. The drug–target network between the active ingredients of TGs and the overlapping genes was constructed, visualized, and analyzed with Cytoscape software. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes enrichment were performed to analyze these genes. Finally, we validated our predictions of the potential targets through docking study.
Results
A total of 55 overlapping genes were discovered. Results suggested that the TGs’ mechanism in SLE treatment was associated with heat shock protein family A member 5, heat shock protein family A member 8, eukaryotic translation elongation factor 1 alpha 1, and so forth with their related 4042 gene network, which regulated ribosome, spliceosome, viral carcinogenesis, Epstein–Barr virus infection signaling, and so forth. Molecular-docking analysis proved that hydrogen bonding was the main form of interaction.
Conclusions
Our research provided the protein targets affected by TGs in SLE treatment. The key targets (CASP3, MAPK1, HIF1A, and so forth) involving 4042 proteins became the multitarget mechanism of TGs in SLE treatment.
TsokosGCLoMSReisPC, et al.New insights into the immunopathogenesis of systemic lupus erythematosus. Nat Rev Rheumatol2016; 12: 716–730. DOI: 10.1038/nrrheum.2016.186.
3.
TsokosGC. Autoimmunity and organ damage in systemic lupus erythematosus. Nat Immunol2020; 21: 605–614. DOI: 10.1038/s41590-020-0677-6.
4.
BakshiJSeguraBTWincupC, et al.Unmet needs in the pathogenesis and treatment of systemic lupus erythematosus. Clin Rev Allergy Immunol2018; 55: 352–367. DOI: 10.1007/s12016-017-8640-5.
WangQShiGZhangY, et al.Deciphering the potential pharmaceutical mechanism of GUI-ZHI-FU-LING-WAN on systemic sclerosis based on systems biology approaches. Sci Rep2019; 9: 355. DOI: 10.1038/s41598-018-36314-2.
7.
JiWLiHGaoF, et al.Effects of tripterygium glycosides on interleukin-17 and CD4+CD25+CD127low regulatory T-cell expression in the peripheral blood of patients with ankylosing spondylitis. Biomed Rep2014; 2: 517–520. DOI: 10.3892/br.2014.262.
8.
PatavinoTBradyDM. Natural medicine and nutritional therapy as an alternative treatment in systemic lupus erythematosus. Altern Med Rev2001; 6: 460–71.
9.
QiuDKaoPN. Immunosuppressive and anti-inflammatory mechanisms of triptolide, the principal active diterpenoid from the Chinese medicinal herb Tripterygium wilfordii Hook. f. Drugs R D2003; 4: 1–18. DOI: 10.2165/00126839-200304010-00001.
10.
WangXShenYWangS, et al.PharmMapper 2017 update: a web server for potential drug target identification with a comprehensive target pharmacophore database. Nucleic Acids Res2017; 45: W356–w360. DOI: 10.1093/nar/gkx374.
11.
WishartDSFeunangYDGuoAC, et al.DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res2018; 46: D1074–d1082. DOI: 10.1093/nar/gkx1037.
12.
AmbergerJSBocchiniCASchiettecatteF, et al.OMIM.org: online mendelian inheritance in man (OMIM), an online catalog of human genes and genetic disorders. Nucleic Acids Res2015; 43: D789–D798. DOI: 10.1093/nar/gku1205.
13.
SafranMDalahIAlexanderJ, et al.GeneCards version 3: the human gene integrator. Database2010; 2010: baq020. DOI: 10.1093/database/baq020.
TangYLiMWangJ, et al.CytoNCA: a cytoscape plugin for centrality analysis and evaluation of protein interaction networks. Biosystems2015; 127: 67–72. DOI: 10.1016/j.biosystems.2014.11.005.
16.
ZhouYZhouBPacheL, et al.Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun2019; 10: 1523. DOI: 10.1038/s41467-019-09234-6.
17.
KanehisaMFurumichiMTanabeM, et al.KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res2017; 45: D353–d361. DOI: 10.1093/nar/gkw1092.
18.
ChinCHChenSHWuHH, et al.cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol2014; 8(Suppl 4): S11. DOI: 10.1186/1752-0509-8-s4-s11.
19.
RizviSMShakilSHaneefM. A simple click by click protocol to perform docking: AutoDock 4.2 made easy for non-bioinformaticians. EXCLI J2013; 12: 831–57.
20.
WangDZhangHLiangJ, et al.A long-term follow-up study of allogeneic mesenchymal stem/stromal cell transplantation in patients with drug-resistant systemic lupus erythematosus. Stem Cell Rep2018; 10: 933–941. DOI: 10.1016/j.stemcr.2018.01.029.
21.
LiuLLuoYZhouM, et al.Tripterygium agents for the treatment of atopic eczema: a Bayesian analysis of randomized controlled trials. Phytomedicine2019; 59: 152914. DOI: 10.1016/j.phymed.2019.152914.
22.
LiuQ. Triptolide and its expanding multiple pharmacological functions. Int Immunopharmacol2011; 11: 377–383. DOI: 10.1016/j.intimp.2011.01.012.
23.
LüSWangQLiG, et al.The treatment of rheumatoid arthritis using Chinese medicinal plants: from pharmacology to potential molecular mechanisms. J Ethnopharmacol2015; 176: 177–206. DOI: 10.1016/j.jep.2015.10.010.
24.
NagataS. Apoptosis and clearance of apoptotic cells. Annu Rev Immunol2018; 36: 489–517. DOI: 10.1146/annurev-immunol-042617-053010.
25.
KrishnanSKiangJGFisherCU, et al.Increased caspase-3 expression and activity contribute to reduced CD3ζ expression in systemic lupus erythematosus T cells. J Immunol2005; 175: 3417–3423. DOI: 10.4049/jimmunol.175.5.3417.
26.
MahajanSDTutinoVMRedaeY, et al.C5a induces caspase-dependent apoptosis in brain vascular endothelial cells in experimental lupus. Immunology2016; 148: 407–419. DOI: 10.1111/imm.12619.
27.
WangLLawHKW. Immune complexes impaired glomerular endothelial cell functions in lupus nephritis. Int J Mol Sci2019; 20: 5281. DOI: 10.3390/ijms20215281.
UekiAIsozakiYTomokuniA, et al.Intramolecular epitope spreading among anti-caspase-8 autoantibodies in patients with silicosis, systemic sclerosis and systemic lupus erythematosus, as well as in healthy individuals. Clin Exp Immunol2002; 129: 556–561. DOI: 10.1046/j.1365-2249.2002.01939.x.
30.
YangXSunBWangH, et al.Increased serum IL-10 in lupus patients promotes apoptosis of T cell subsets via the caspase 8 pathway initiated by Fas signaling. J Biomed Res2015; 29: 232–240. DOI: 10.7555/jbr.29.20130037.
31.
CedeñoSCifarelliDFBlasiniAM, et al.Defective activity of ERK-1 and ERK-2 mitogen-activated protein kinases in peripheral blood T lymphocytes from patients with systemic lupus erythematosus: potential role of altered coupling of Ras guanine nucleotide exchange factor hSos to adapter protein Grb2 in lupus T cells. Clin Immunol2003; 106: 41–49. DOI: 10.1016/s1521-6616(02)00052-9.
32.
Garcia-RodriguezSCallejas-RubioJLOrtego-CentenoN, et al.Altered AKT1 and MAPK1 gene expression on peripheral blood mononuclear cells and correlation with T-helper-transcription factors in systemic lupus erythematosus patients. Mediators Inflammation2012; 2012: 1–14. DOI: 10.1155/2012/495934.
33.
LiuYDengWMengQ, et al.CD8+iTregs attenuate glomerular endothelial cell injury in lupus-prone mice through blocking the activation of p38 MAPK and NF-κB. Mol Immunol2018; 103: 133–143. DOI: 10.1016/j.molimm.2018.09.006.
34.
ZhaoXLiSWangZ, et al.miR-101-3p negatively regulates inflammation in systemic lupus erythematosus via MAPK1 targeting and inhibition of the NF-κB pathway. Mol Med Rep2021; 23: 23. DOI: 10.3892/mmr.2021.11998.
35.
HauptYMayaRKazazA, et al.Mdm2 promotes the rapid degradation of p53. Nature1997; 387: 296–299. DOI: 10.1038/387296a0.
36.
AllamRSayyedSGKulkarniOP, et al.Mdm2 promotes systemic lupus erythematosus and lupus nephritis. J Am Soc Nephrol2011; 22: 2016–2027. DOI: 10.1681/asn.2011010045.
37.
MaCWeiJZhanF, et al.Urinary hypoxia-inducible factor-1alpha levels are associated with histologic chronicity changes and renal function in patients with lupus nephritis. Yonsei Med J2012; 53: 587–592. DOI: 10.3349/ymj.2012.53.3.587.
38.
DengWRenYFengX, et al.Hypoxia inducible factor-1 alpha promotes mesangial cell proliferation in lupus nephritis. Am J Nephrol2014; 40: 507–515. DOI: 10.1159/000369564.
39.
LiXQiSMWangY, et al. Antidepressant effect of electroacupuncture on modulating the expression of c‐Fos/AP ‐1 through the JNK signaling pathway. Anat Rec2021; 304: 2480–2493. DOI: 10.1002/ar.24740.
40.
KatsuyamaTTsokosGCMoultonVR. Aberrant T cell signaling and subsets in systemic lupus erythematosus. Front Immunol2018; 9: 1088. DOI: 10.3389/fimmu.2018.01088.
41.
SchonthalerHBGuinea-ViniegraJWagnerEF. Targeting inflammation by modulating the Jun/AP-1 pathway. Ann Rheum Dis2011; 70(Suppl 1): i109–i112. DOI: 10.1136/ard.2010.140533.
42.
WangJNuiteMMcAlindonT. Association of estrogen and aromatase gene polymorphisms with systemic lupus erythematosus. Lupus2010; 19: 734–740. DOI: 10.1177/0961203309359517.
43.
SthoegerZMZingerHMozesE. Beneficial effects of the anti-oestrogen tamoxifen on systemic lupus erythematosus of (NZBxNZW)F1 female mice are associated with specific reduction of IgG3 autoantibodies. Ann Rheum Dis2003; 62: 341–346. DOI: 10.1136/ard.62.4.341.
44.
HaydenMSGhoshS. NF-κB in immunobiology. Cell Res2011; 21: 223–244. DOI: 10.1038/cr.2011.13.
45.
FillatreauSManfroiBDörnerT. Toll-like receptor signalling in B cells during systemic lupus erythematosus. Nat Rev Rheumatol2021; 17: 98–108. DOI: 10.1038/s41584-020-00544-4.
46.
ZhangHSunSC. NF-κB in inflammation and renal diseases. Cell Biosci2015; 5: 63. DOI: 10.1186/s13578-015-0056-4.
47.
SuBYeHYouX, et al.Icariin alleviates murine lupus nephritis via inhibiting NF-κB activation pathway and NLRP3 inflammasome. Life Sci2018; 208: 26–32. DOI: 10.1016/j.lfs.2018.07.009.
48.
JiLHouXLiuW, et al.Paeoniflorin inhibits activation of the IRAK1-NF-κB signaling pathway in peritoneal macrophages from lupus-prone MRL/lpr mice. Microb Pathogenesis2018; 124: 223–229. DOI: 10.1016/j.micpath.2018.08.051.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
